In pursuit of progress: Mutlimodality strategies will form the cornerstone of cure esophageal cancer

Gastrointestinal Cancer Research

Volumn 3, Issue 2, 2009, Pages 74-76

  Czito, Brian G ^a   Willett, Christopher G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; PACLITAXEL; PANITUMUMAB; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ADJUVANT CHEMOTHERAPY; BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; ESOPHAGUS CANCER; EXTERNAL BEAM RADIOTHERAPY; HEMOPTYSIS; HUMAN; PERFORATION; PERIOPERATIVE PERIOD; RADIATION DOSE; SURVIVAL RATE;

EID: 77953389896     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (30)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Hulscher JB, van Sandick JW, de Boer AG, et al: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662-1669, 2002
3. Kelsen DP, Ginsberg R, Pajak TF, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984, 1998
4. Law SY, Fok M, Wong J: Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83:107-111, 1996
5. Urba SG, Orringer MB, Turrisi A, et al: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305-313, 2001
6. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996
7. Bosset JF, Gignoux M, Triboulet JP, et al: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161-167, 1997
8. Burmeister BH, Smithers BM, Gebski V, et al: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6:659-668, 2005
9. Tepper J, Krasna MJ, Niedzwiecki D, et al: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086-1092, 2008
10. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538-543, 2003
11. Fiorica F, Di Bona D, Schepis F, et al: Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53:925-930, 2004
12. Malthaner RA, Wong RK, Rumble RB, et al: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med 2:35, 2004
13. Greer SE, Goodney PP, Sutton JE, et al: Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 137: 172-177, 2005
14. Gebski V, Burmeister B, Smithers BM, et al: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226-234, 2007
15. Bedenne L, Michel P, Bouché O, et al: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160-1168, 2007
16. Stahl M, Stuschke M, Lehmann N, et al: Chemo radiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317, 2005
17. Herskovic A, Martz K, al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992
18. Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623-1627, 1999
19. Minsky BD, Pajak TF, Ginsberg RJ, et al: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167-1174, 2002
20. Gaspar LE, Winter K, Kocha WI, et al: A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer 88:988-995, 2000
21. Ilson D, Bains M, Rizk N, et al: Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: preliminary safety analysis. Proc Am Soc Clin Oncol 2009 Gastrointestinal Cancers Symposium (GCS); January 15-17, 2009; San Francisco, CA (abstr 79)
22. Safran H, Suntharalingam M, Dipetrillo T, et al: Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity. Int J Radiat Oncol Biol Phys 70:391-395, 2008
23. Czito B, Willett C, Hurwitz H, et al: A Phase I study of capecitabine, oxaliplatin and panitumumab and external beam radiation therapy for patients with esophageal cancer. Radiotherapy and Oncology 90:S54, 2009
24. Allum WH, Fogarty PJ, Stenning SP, et al: Long term results of the MRC OEO2 randomized trial of surgery with or without preoperative chemotherapy in resectable esophageal cancer. Proc Am Soc Clin Oncol 2008 Gastrointestinal Cancers Symposium (GCS); January 25-27, 2008; Orlando, Florida (abstr 9)
25. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
26. Boige V, Pignon J, Saint-Aubert B, et al: Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25:18S, 2007 (abstr 4510)
27. Urschel JD, Vasan H, Blewett CJ: A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183:274-279, 2002
28. Kaklamanos IG, Walker GR, Ferry K, et al: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754-761, 2003
29. Stahl M, Walz MK, Stuschke M, et al: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851-856, 2009
30. Ott K, Weber WA, Lordick F, et al: Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24:4692-4698, 2006